(R)-2-Amino-2-(3-(trifluoromethyl)phenyl)ethanol, 95.0%, 1g

2-(Benzyloxy)-5-(tert-butyl)benzaldehyde, 95.0%, 250mg

Fmoc-(1S,2S)-2-aminocyclohexane carboxylic acid, 98.0%, 5g

Dimethyl(4-vinylphenyl)silane, 95.0%, 25g

Methyl 4-chloro-1H-pyrrolo[2,3-b]pyridine-3-carboxylate, 95.0%, 5g

N-Acetyl-L-histidine Monohydrate, 97.00%, 1g

2-(3,4-Dichlorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 5g

2-{2-[(4-chlorophenyl)sulfanyl]ethyl}piperidine hydrochloride, 95.0%, 500mg

2-Chloro-4-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 96%, 1g

(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)(piperidin-1-yl)methanone, 95.0%, 250mg

1-(2,3-Di(thiophen-2-yl)quinoxalin-6-yl)-3-(2-methoxyethyl)urea, 98%, 10mg

Mini centrifuge with specimen carrier rotor, 1 piece

tert-Butyl (2-chloroethyl)(methyl)carbamate, 95%, 100mg